Bone Biologics Corporation

NasdaqCM:BBLG Stock Report

Market Cap: US$2.7m

Bone Biologics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jeff Frelick

Chief executive officer

US$376.6k

Total compensation

CEO salary percentage79.7%
CEO tenure5.6yrs
CEO ownership0.09%
Management average tenureno data
Board average tenure2.1yrs

Recent management updates

Recent updates

Companies Like Bone Biologics (NASDAQ:BBLG) Are In A Position To Invest In Growth

Jun 07
Companies Like Bone Biologics (NASDAQ:BBLG) Are In A Position To Invest In Growth

Bone Biologics prices $5.1M underwritten public offering

Oct 07

We're Not Very Worried About Bone Biologics' (NASDAQ:BBLG) Cash Burn Rate

Mar 18
We're Not Very Worried About Bone Biologics' (NASDAQ:BBLG) Cash Burn Rate

CEO Compensation Analysis

How has Jeff Frelick's remuneration changed compared to Bone Biologics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$7m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$6m

Dec 31 2023US$377kUS$300k

-US$9m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$415kUS$300k

-US$1m

Sep 30 2022n/an/a

-US$3m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$290kUS$245k

-US$2m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$2m

Dec 31 2020US$300kUS$240k

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019US$300kUS$240k

-US$3m

Sep 30 2019n/an/a

-US$4m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018US$300kUS$240k

-US$4m

Compensation vs Market: Jeff's total compensation ($USD376.60K) is below average for companies of similar size in the US market ($USD642.68K).

Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.

CEO

Jeff Frelick (58 yo)

5.6yrs

Tenure

US$376,600

Compensation

Mr. Jeffrey Frelick, also known as Jeff, has been the President and Chief Executive Officer at Bone Biologics Corporation since June 28, 2019. He served as Chief Operating Officer at Bone Biologics, Corp....

Board Members

NamePositionTenureCompensationOwnership
Bruce Stroever
Independent Chairman of the Board13yrsUS$76.88k0%
$ 0
Robert Gagnon
Independent Directorless than a yearno data0%
$ 0
Siddhesh Angle
Independent Director3.3yrsUS$76.88k0%
$ 0
Phillip Meikle
Directorless than a yearno datano data

2.1yrs

Average Tenure

50yo

Average Age

Experienced Board: BBLG's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 12:32
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bone Biologics Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bradley SorensenZacks Small-Cap Research